 Virios Therapeutics, Inc. NASDAQ:VIRI Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET CompanyParticipants Greg Duncan - CEO Ralph Grosswald - SVP, Operations Angela Walsh - SVP, Finance Treasurer Conference Call Participants David Bautz - Zacks Small Cap Research Sean Lee - H.C. Wainwright Co., LLC Operator Good morning, and welcome to the Virios Therapeutics, Inc. Second Quarter 2022 Financial Results Conference Call. 